相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer
Fei Ma et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer
Hua Zhang et al.
CANCER CELL (2020)
Reliability of CT radiomic features reflecting tumour heterogeneity according to image quality and image processing parameters
Bum Woo Park et al.
SCIENTIFIC REPORTS (2020)
Treating non-responders: pitfalls and implications for cancer immunotherapy trial design
Zhenzhen Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Hypoxia-Driven Immune Escape in the Tumor Microenvironment
Alyssa Vito et al.
CELLS (2020)
Cellular immunotherapy plus chemotherapy ameliorates survival in gastric cancer patients: a meta-analysis
Guoming Hu et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)
Tumor heterogeneity estimation for radiomics in cancer
Ani Eloyan et al.
STATISTICS IN MEDICINE (2020)
De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors
Samuel T. Workenhe et al.
COMMUNICATIONS BIOLOGY (2020)
Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity
Gabriela S. Kinker et al.
NATURE GENETICS (2020)
Pre-existing Functional Heterogeneity of Tumorigenic Compartment as the Origin of Chemoresistance in Pancreatic Tumors
Sahil Seth et al.
CELL REPORTS (2019)
A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T-cell Responses, Impacting Tumor Challenge
Elizabeth K. Duperret et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma
Lili Ren et al.
ONCOIMMUNOLOGY (2019)
Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis
Urania Dafni et al.
LUNG CANCER (2019)
Genome-wide cell-free DNA fragmentation in patients with cancer
Stephen Cristiano et al.
NATURE (2019)
Treatment May Be Harmful: Mechanisms/Prediction/Prevention of Drug-Induced DNA Damage and Repair in Multiple Myeloma
Claire Gourzones et al.
FRONTIERS IN GENETICS (2019)
Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models
Peter R. Hoffmann et al.
FRONTIERS IN ONCOLOGY (2019)
Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer
Lichun Ma et al.
CANCER CELL (2019)
Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens
Gerald P. Linette et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors
K. M. Heinhuis et al.
ANNALS OF ONCOLOGY (2019)
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O'Donnell et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy
Zuan-Fu Lim et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Comprehensive Characterization of Cancer Driver Genes and Mutations
Matthew H. Bailey et al.
CELL (2018)
Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
Charissa Kim et al.
CELL (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss Variants
Andrew Nguyen et al.
CELL REPORTS (2018)
Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade
Charlotte E. Ariyan et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Intra-tumour diversification in colorectal cancer at the single-cell level
Sophie F. Roerink et al.
NATURE (2018)
Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T79OM-Positive Lung Cancer and Acquired Resistance to Osimertinib
Geoffrey R. Oxnard et al.
JAMA ONCOLOGY (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Overview on Clinical Relevance of Intra-Tumor Heterogeneity
Giorgio Stanta et al.
FRONTIERS IN MEDICINE (2018)
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
Valsamo Anagnostou et al.
CANCER DISCOVERY (2017)
Direct detection of early-stage cancers using circulating tumor DNA
Jillian Phallen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Antigen Loss variants: catching Hold of escaping Foes
Maulik Vyas et al.
FRONTIERS IN IMMUNOLOGY (2017)
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
Sidharth V. Puram et al.
CELL (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Neoantigen landscape dynamics during human melanoma-T cell interactions
Els M. E. Verdegaal et al.
NATURE (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer
Justin F. Gainor et al.
CANCER DISCOVERY (2016)
A multi-antigen vaccine in combination with an immunotoxin targeting tumor-associated fibroblast for treating murine melanoma
Jinxu Fang et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment
Marie-Claude Bourgeois-Daigneault et al.
BREAST CANCER RESEARCH (2016)
Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
Debraj GuhaThakurta et al.
CLINICAL CANCER RESEARCH (2015)
Combined cellular immunotherapy and chemotherapy improves clinical outcome in patients with gastric carcinoma
Jiuwei Cui et al.
CYTOTHERAPY (2015)
Spatiotemporal T790M Heterogeneity in Individual Patients with EGFR-Mutant Non-Small-Cell Lung Cancer after Acquired Resistance to EGFR-TKI
Akito Hata et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor et al.
NATURE (2015)
Studying clonal dynamics in response to cancer therapy using high-complexity barcoding
Hyo-eun C. Bhang et al.
NATURE MEDICINE (2015)
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
Elena Sotillo et al.
CANCER DISCOVERY (2015)
Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations
W. Joost Lesterhuis et al.
SCIENTIFIC REPORTS (2015)
Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine
Yinin Hu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
A novel multi-epitope peptide vaccine against cancer: An in silico approach
Navid Nezafat et al.
JOURNAL OF THEORETICAL BIOLOGY (2014)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin et al.
NATURE (2014)
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav et al.
NATURE (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
Tumor clone dynamics in lethal prostate cancer
Suzanne Carreira et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
DNA-Damaging Agents in Cancer Chemotherapy: Serendipity and Chemical Biology
Kahlin Cheung-Ong et al.
CHEMISTRY & BIOLOGY (2013)
Combining Oncolytic HSV-1 with Immunogenic Cell Death-Inducing Drug Mitoxantrone Breaks Cancer Immune Tolerance and Improves Therapeutic Efficacy
Samuel T. Workenhe et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Chronic hypoxia compromises repair of DNA double-strand breaks to drive genetic instability
Ramya Kumareswaran et al.
JOURNAL OF CELL SCIENCE (2012)
Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer
Eitan Amir et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Steffen Walter et al.
NATURE MEDICINE (2012)
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
Renier J. Brentjens et al.
BLOOD (2011)
Stability of Estrogen Receptor Status in Breast Carcinoma A Comparison Between Primary and Metastatic Tumors With Regard to Disease Course and Intervening Systemic Therapy
Yun Gong et al.
CANCER (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Tumor heterogeneity: Causes and consequences
Andriy Marusyk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2010)
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Peter J. Campbell et al.
NATURE (2010)
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Shinichi Yachida et al.
NATURE (2010)
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Magali Olivier et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS)
Alastair M. Thompson et al.
BREAST CANCER RESEARCH (2010)
The consensus coding sequences of human breast and colorectal cancers
Tobias Sjoeblom et al.
SCIENCE (2006)
Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivo
L Sanchez-Perez et al.
CANCER RESEARCH (2005)
Radiation-induced genomic instability and its implications for radiation carcinogenesis
L Huang et al.
ONCOGENE (2003)
Determinant spreading and tumor responses after peptide-based cancer immunotherapy
A Ribas et al.
TRENDS IN IMMUNOLOGY (2003)
Epitope spreading in immunemediated diseases: Implications for immunotherapy
CL Vanderlugt et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A
MA Markiewicz et al.
INTERNATIONAL IMMUNOLOGY (2001)
分享论文
